Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean W Felsher

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Investigation|December 3, 2011
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisRyan A Hlady, Slavomira Novakova, Jana Opavska, et al.
Cell Chemical Biology|August 13, 2025
Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancersWadie D Mahauad-Fernandez, Yu Chi Yang, Ian Lai, et al.
Blood|August 15, 2013
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cellsStephanie Beurlet, Nader Omidvar, Petra Gorombei, et al.
Nature Cancer|September 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual diseaseLea Lemaitre, Nia Adeniji, Akanksha Suresh, et al.
Cell Metabolism|September 22, 2015
MYC Disrupts the Circadian Clock and Metabolism in Cancer CellsBrian J Altman, Annie L Hsieh, Arjun Sengupta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 11, 2020
The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure ThemMartyn T Smith, Kathryn Z Guyton, Nicole Kleinstreuer, et al.
Nature Communications|June 9, 2017
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinomaSean T Bailey, Aleisha M Smith, Jordan Kardos, et al.
The Journal of Clinical Investigation|April 28, 2015
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesisYan Xiang, Zachary E Stine, Jinsong Xia, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
EcDNA-borne PVT1 fusion stabilizes oncogenic mRNAsHyerim Yi, Shu Zhang, Jason Swinderman, et al.
Nature Biotechnology|October 20, 2020
Mitochondrial copper depletion suppresses triple-negative breast cancer in miceLiyang Cui, Arvin M Gouw, Edward L LaGory, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Investigation|December 3, 2011
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisRyan A Hlady, Slavomira Novakova, Jana Opavska, et al.
Cell Chemical Biology|August 13, 2025
Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancersWadie D Mahauad-Fernandez, Yu Chi Yang, Ian Lai, et al.
Blood|August 15, 2013
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cellsStephanie Beurlet, Nader Omidvar, Petra Gorombei, et al.
Nature Cancer|September 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual diseaseLea Lemaitre, Nia Adeniji, Akanksha Suresh, et al.
Cell Metabolism|September 22, 2015
MYC Disrupts the Circadian Clock and Metabolism in Cancer CellsBrian J Altman, Annie L Hsieh, Arjun Sengupta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 11, 2020
The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure ThemMartyn T Smith, Kathryn Z Guyton, Nicole Kleinstreuer, et al.
Nature Communications|June 9, 2017
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinomaSean T Bailey, Aleisha M Smith, Jordan Kardos, et al.
The Journal of Clinical Investigation|April 28, 2015
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesisYan Xiang, Zachary E Stine, Jinsong Xia, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
EcDNA-borne PVT1 fusion stabilizes oncogenic mRNAsHyerim Yi, Shu Zhang, Jason Swinderman, et al.
Nature Biotechnology|October 20, 2020
Mitochondrial copper depletion suppresses triple-negative breast cancer in miceLiyang Cui, Arvin M Gouw, Edward L LaGory, et al.
Pageof 15